Difference between revisions of "CT Volumetry Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
m
 
(289 intermediate revisions by 6 users not shown)
Line 1: Line 1:
−
==Project Snapshot==
+
{{TOCright}}
−
*Compliance Documents: [[Media:Approach to Compliance 2011 08 15.pdf|QIBA Approach to Compliance-- ''Andrew J. Buckler, MS, Program Director, QIBA 08.15.11'']]
+
:Co-chairs: Rudresh Jarecha, MBBS, DNB, DMRE; Ehsan Samei, PhD and Ritu Gill, MD, MPH
 +
:RSNA Staff Support: Julie Lisiecki
 +
* [http://tinyurl.com/QIBA-CT-Vol-Roster Roster]
 +
* [https://docs.google.com/spreadsheets/d/1qbBHaJNTAqHnAcmCTHsNfDph7hMyJ3NoUjYSdilVw8w/edit#gid=267283460 Attendance & Voting Privileges]
  
−
*[[Media:Why_QIBA_CT_specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
+
==Meetings==
−
*[[Media: Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
+
* Tcons are held periodically. Contact RSNA Staff for details.
−
'''[[:Category:Datasets| See the Datasets page]]''' of the [[Catalog|QIBA Resource Catalog]]
 
  
−
==Meetings / Call Summaries==
 
−
*[[Call Summaries]]
 
  
−
==Profile Development==
+
'''Recent Call Summaries:'''
 +
*[[Media:03 21 2023 QIBA CT Volumetry BC Call-FINAL.pdf|03.21.2023 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:11 01 2022 QIBA CT Volumetry BC Call-FINAL.pdf|11.01.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:10 10 2022 QIBA CT Volumetry BC Call-FINAL.pdf|10.10.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:08 17 2022 QIBA CT Volumetry BC Call-FINAL.pdf|08.17.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:06 29 2022 QIBA CT Volumetry BC Call-FINAL.pdf|06.29.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:05 26 2022 QIBA CT Volumetry BC Call-FINAL.pdf|05.26.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:04 20 2022 QIBA CT Volumetry BC Call-FINAL.pdf|04.20.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:03 15 2022 QIBA CT Volumetry BC Call-FINAL.pdf|03.15.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:02 15 2022 QIBA CT Volumetry BC Call-FINAL.pdf|02.15.2022 QIBA CT Volumetry BC Call Summary]]
  
−
===Lung Nodule Assessment in CT Screening===
 
−
Status - Initial Profile Development
 
  
−
*[[Media:Strawman Small Nodule Claim.doc|Mission Statement (draft as of 12.7.12]]
+
'''''[[CT Volumetry BC Call Summaries Archive]]'''''
−
*[[Media:Strawman Small Nodule Claim.doc|Strawman Profile Claim Language]]
 
−
*[[Media:QIBA CT Vol TumorVolumeChangeProfile v2.2 ReviewedDraft 08AUG2012.doc|CT Profile Template]]
 
−
*[[Media:JMulshine.pdf|QIBA Profile: Lung Nodule Assessment in CT Screening, v1.0 (JM) ''25-SEP-2012'']]
 
−
*[[Media:QIBA CT Vol LungNoduleAssessmentInCTScreening v1.0 DG.doc|QIBA Profile: Lung Nodule Assessment in CT Screening, v1.0 (DG) ''25-OCT-2012'']]
 
  
−
*[[2012 Call Summaries]]
+
==Profile Development==
−
 
+
'''Streamlined Profile (also on Profile page)'''
−
===Advanced Disease Profile===
+
* [[Media:QIBACTVol_TumorVolumeChange(2022)-20220721.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2022-07-21 Streamlined Profile]]
−
Status - Now Resolving Public Comment
+
:* 32 pages including Conformance Checklists
−
 
 
−
*[[Media:QIBA Vol-CT AdvDisease v2.2 Profile DraftReviewed 08AUG2012.doc|QIBA Profile: CT Volumetry AdvDisease v2.2 Profile Draft]] ''(Current Profile Draft) 2012-08-08''
 
−
 
 
−
*[[Media:QIBA Vol-CT AdvDiseaseV2 2 pre-Reviewed 2012-07-16.doc|QIBA CT Volumetry AdvDiseasev2.2 Profile Draft 2012-07-16]] ''(Profile Draft) 2012-07-16''
 
  
−
*[[Media:QIBA Vol-CT AdvDiseaseV2.1 Profile draft 2012.04.22.doc|QIBA CT Volumetry AdvDiseaseV2.1 Profile Draft 2012-04-22]] ''(Profile Draft) 2012-04-22''
 
  
−
*[[Media:QIBA Vol-CT AdvDiseaseV2 0 Public Comment Resolution 2012-04-19.doc|QIBA CT Volumetry AdvDiseaseV2.0 Public Comment Resolution 2012-04-19]] ''(Public Comment & Resolution) 2012-04-19''
+
'''Status - Balloting Streamlined Profile'''
 +
*[[Media:QIBA Profile Streamlining Proposal - CTVol TumorVolumeChange-20220303.docx| CT Tumor Volume Change Profile - Streamlined]] Draft 2022.03.03
 +
*[[Media:QIBA Profile Streamlining Proposal - CTVol TumorVolumeChange-20211209.docx| CT Tumor Volume Change Profile - Streamlined]] Draft 2021.12.09
  
−
*[[Media:2011 07 28 Profile CT Advanced Disease V2 0f.pdf|Advanced Disease Profile V2 0f.pdf]] ''(Original Public Comment Draft) 2011-07-28''
+
The Technically Confirmed Profile is on the [[Profiles]] page.
  
 +
'''Stage 4 Planning'''
 +
:* [https://docs.google.com/document/d/1Wcmkzp8N_2lLL-FCykNPwgsn1BJOs7Z9A1ZyTIkuGCo/edit?usp=sharing Draft Stage 4 Plan - Google Doc]
  
−
[[Archived Versions]] of QIBA draft documents.
+
'''Past and Future'''
 +
:* [[Archived Versions#Advanced_disease|Archived Versions]] of Profile-related documents.
 +
:* [[CTV-AD Considerations for Future Editions|Considerations for Future Editions of CTV-AD]]
  
 
==Groundwork Projects==
 
==Groundwork Projects==
 
These projects investigate (and resolve) scientific questions underlying QIBA Profile work.  
 
These projects investigate (and resolve) scientific questions underlying QIBA Profile work.  
 +
* [[VolCT - Group 1A]] - Analyze Bias/Variance where Ground Truth is Known Deterministically
 
* [[VolCT - Group 1B]] - Focus on Volume Change Analysis of Pulmonary Nodules in Diagnostic Settings  
 
* [[VolCT - Group 1B]] - Focus on Volume Change Analysis of Pulmonary Nodules in Diagnostic Settings  
 
* [[VolCT - Group 1C]] - Model Sources of Variability from a Systems Engineering Analysis
 
* [[VolCT - Group 1C]] - Model Sources of Variability from a Systems Engineering Analysis
−
* [[VolCT - Group 3A]] - Characterize variability due to algorithm using phantoms
+
* [[VolCT - Group 3A]] - Characterize variability due to algorithms (using phantoms / clinical data)
 
* [[VolCT - Group 3B]] - Characterize clinical utility/efficacy with respect to clinical endpoints
 
* [[VolCT - Group 3B]] - Characterize clinical utility/efficacy with respect to clinical endpoints
 
* [[VolCT - Colorado Group]] - Quantifying variability in measurement of pulmonary nodule
 
* [[VolCT - Colorado Group]] - Quantifying variability in measurement of pulmonary nodule
  
 
*[[Media:NIBIB-2 Proposal for CT Volumetry 16APR2012.pdf|NIBIB-2 Proposal for CT Volumetry]]''16-APR-2012''
 
*[[Media:NIBIB-2 Proposal for CT Volumetry 16APR2012.pdf|NIBIB-2 Proposal for CT Volumetry]]''16-APR-2012''
−
 
−
==Working Documents==
 
−
<<We should tidy up this section and archive or label accordingly>>
 
−
 
−
No longer active:
 
−
*Advanced Disease:
 
−
** [[Media:2011.02.28.Profile CT advanced disease V1 6.doc|VIA Profile v1.6]] ''02/28/2011''
 
−
** [[Media:2011.01.09.QIBA VIA Profile V1 5.doc|VIA Profile v1.5]] ''01/09/2011''
 
−
*[[Media: 2010.09.09.UPICT_CT_Lung_Nodule_V1_4a.cleaner copy.doc|VIA Protocol v1.4]] ''Word version known as field test v1.0, 09-09-2010''
 
−
*[[Media: 2010.09.09_UPICT_V1_4_1_FIELD_TEST.doc|VIA Protocol v1.4.1]] ''(Early field test protocol draft) 2010-09-09''
 
−
 
−
*Small Nodule:
 
−
** [[Media:2011.03.12 Profile CT small nodule V0 6.doc|Small Pulmonary Nodule Profile v0.6]] ''03/12/2011''
 
−
** [[Media:2011.02.14 Profile CT early disease V0 4.doc|Small Pulmonary Nodule Profile v0.4]] ''02/14/2011''
 
−
* [http://docs.google.com/Doc?docid=0ASSwlnzdbPEGZHJyc2pxcF8zcHFkdnhqY3A&hl=en| UPICT Template for CT Lung Nodule Protocol] ''Google doc version of v1.4 WIP''
 
−
*[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
 
−
*[[Media:Work breakdown for volCT-formatted.doc| Work Breakdown for Volumetric CT]] ''07.12.10''
 
−
* [[VolCT - Group 1A]] - Analyze Bias/Variance where Ground Truth is Known Deterministically
 
−
*[[Media:2009 12 31 Review of Volumetric Image Analysis in Patients with Solid Tumors.long version.doc|2009 12 31 Review of Volumetric Image Analysis in Patients with Solid Tumors - long version]]
 
−
*[[Media: QIBA_Vol-CT_Profile_v1.1-ABuckler-20090903.doc|VIA Profile v1.1]] ''Word version 09-03-2009''
 
−
* [[Profile: CT Lung Nodule Volume Measurement for Primary/Regional Nodes and Metastatic Sites]] ''Last updated 6/2009''
 
−
* [[Profile: CT Lung Nodule - Small Nodule in Neoadjuvant Setting]] ''Last updated 6/2009''
 
−
*[[Media:2008.09.15.Validation_Roadmap_VOL-CT_Image_Analysis.pdf|Validation Roadmap - P. David Mozley, MD]]
 
−
*[[Media:Mr ODonnell QIBA Process Roadmap 20090629.ppt.pdf|Thoughts on the QIBA Process: Profiles, UPICT & Measurements by Kevin O’Donnell-20090629]]
 
−
* [[VolCT - Group 2]] - Set Standards for using Volumetric Imaging in Clinical Trials
 
−
* [[Profile Strategy for Vol CT]]
 
−
* [[Initial Target Selection]] - describing the early prioritization discussions and settling on Lung Tumor Volumes
 
−
*[[Media:2008.12.16.Sources_of_Variability_-_Andrew_Buckler.xls|Sources of Variability - Andrew Buckler]]
 
  
 
==Reference Materials==
 
==Reference Materials==
  
 +
'''2012'''
 
*Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
 
*Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
 
**[[Media:ATCC is an independent private nonprofit 7-3-12.pdf|ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.]]
 
**[[Media:ATCC is an independent private nonprofit 7-3-12.pdf|ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.]]
 +
*[[Media:Why QIBA CT specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
  
−
 
+
'''2011'''
 
*Dr Petrick's 2011 SPIE Presentation Materials
 
*Dr Petrick's 2011 SPIE Presentation Materials
 
*[[Media:Spie2011 NP QIBA1A-Talk-v05-final-1.pdf|“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Talk]]
 
*[[Media:Spie2011 NP QIBA1A-Talk-v05-final-1.pdf|“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Talk]]
 
*[[Media:Spie2011 NP QIBA1A-Paper-v08-final-2.pdf|“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Paper]]
 
*[[Media:Spie2011 NP QIBA1A-Paper-v08-final-2.pdf|“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Paper]]
 +
*Compliance Documents: [[Media:Approach to Compliance 2011 08 15.pdf|QIBA Approach to Compliance-- ''Andrew J. Buckler, MS, Program Director, QIBA 08.15.11'']]
  
 +
'''2010'''
 +
*[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
 +
*[[Media:Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
  
 +
==Reference Articles==
 
*Are we ready? A time for measurement of physiological parameters of the lung using multidetector row CT scans. Hatabu H. Acad Radiol. 2009 Mar; 16(3):249. [http://www.academicradiology.org/issues/contents?issue_key=S1076-6332(09)X0002-4 Academic Radiology]
 
*Are we ready? A time for measurement of physiological parameters of the lung using multidetector row CT scans. Hatabu H. Acad Radiol. 2009 Mar; 16(3):249. [http://www.academicradiology.org/issues/contents?issue_key=S1076-6332(09)X0002-4 Academic Radiology]
−
 
 
* [http://radiology.rsnajnls.org/cgi/content/full/243/2/527#T2 Radiology 2007 - Coronary Calcium Scoring] - This paper by Dr. McCollough et al is may be seen to be analaogous to our work in that it addresses  similar issues (e.g. achieving "standard" noise levels).  It could be thought of as an early draft of a Calcium Scoring profile, including both groundwork and equipment specifications.
 
* [http://radiology.rsnajnls.org/cgi/content/full/243/2/527#T2 Radiology 2007 - Coronary Calcium Scoring] - This paper by Dr. McCollough et al is may be seen to be analaogous to our work in that it addresses  similar issues (e.g. achieving "standard" noise levels).  It could be thought of as an early draft of a Calcium Scoring profile, including both groundwork and equipment specifications.
 
*Helical multidetector row quantitative computed tomography (QCT) precision. Bligh M, Bidaut L, White RA, Murphy WA Jr, Stevens DM, Cody DD. Acad Radiol. 2009 Feb; 16(2):150-9. [http://www.academicradiology.org/article/S1076-6332(08)00499-6/abstract Academic Radiology]
 
*Helical multidetector row quantitative computed tomography (QCT) precision. Bligh M, Bidaut L, White RA, Murphy WA Jr, Stevens DM, Cody DD. Acad Radiol. 2009 Feb; 16(2):150-9. [http://www.academicradiology.org/article/S1076-6332(08)00499-6/abstract Academic Radiology]
 
*Comparison of the accuracy of CT volume calculated by circumscription to prolate ellipsoid volume (bidimensional measurement multiplied by coronal long axis). Rkein AM, Harrigal C, Friedman AC, Persky D, Krupinski E. Acad Radiol. 2009 Feb; 16(2):181-6. [http://www.academicradiology.org/article/S1076-6332(08)00530-8/abstract Academic Radiology]
 
*Comparison of the accuracy of CT volume calculated by circumscription to prolate ellipsoid volume (bidimensional measurement multiplied by coronal long axis). Rkein AM, Harrigal C, Friedman AC, Persky D, Krupinski E. Acad Radiol. 2009 Feb; 16(2):181-6. [http://www.academicradiology.org/article/S1076-6332(08)00530-8/abstract Academic Radiology]
  
 +
*[[Archive - Initial Target Selection and Roadmap]]
  
−
*[[Media:QIBA CT-Volumetry Roster.pdf|QIBA CT-Volumetry Technical Committee Roster]]
+
==QIBA Funded Projects==
−
 
 
−
==Round 1 of QIBA Funded Projects==
 
  
 +
'''Round 1'''
 
*[[Duke University]]
 
*[[Duke University]]
 
*[[Columbia University Medical Center]]
 
*[[Columbia University Medical Center]]
Line 104: Line 87:
 
*[[CoreLab Partners, Inc.]]
 
*[[CoreLab Partners, Inc.]]
  
−
==Round 2 of QIBA Funded Projects==
+
'''Round 2'''
−
 
 
 
*[[CoreLab Partners, Inc., Round-2]]
 
*[[CoreLab Partners, Inc., Round-2]]
 
*[[David Geffen School of Medicine at UCLA, Department of Radiology,Round-2]]
 
*[[David Geffen School of Medicine at UCLA, Department of Radiology,Round-2]]
 +
 +
'''Round 3'''
 +
*[[Media:Second 3A Statistical and Image Processing Analysis.pdf| Project (F) Second 3A Statistical and Image Processing Analysis (Elucid Bioimaging Inc.)]]
 +
 +
'''Round 4'''
 +
*[[Media:Methodology and Reference Image Set for Volumetric Characterization and Compliance.pdf| Project (Q) Phantoms Methodology and Reference Image Set for Volumetric Characterization and Compliance (Duke University)]]
 +
 +
*[[Media:Phantoms for CT Volumetry of Hepatic and Nodal Metastasis.pdf| Project (S) Phantoms for CT Volumetry of Hepatic and Nodal Metastasis (CUMC)]]
 +
 +
'''Round 5'''
 +
*[[Media:Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization.pdf| Project (C) Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization (Duke University)]]
 +
 +
'''Round 6'''
 +
*[[Media:Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology.pdf| Project (S) Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology (Duke University)]]

Latest revision as of 16:08, 13 April 2023

Co-chairs: Rudresh Jarecha, MBBS, DNB, DMRE; Ehsan Samei, PhD and Ritu Gill, MD, MPH
RSNA Staff Support: Julie Lisiecki

Meetings

  • Tcons are held periodically. Contact RSNA Staff for details.


Recent Call Summaries:


CT Volumetry BC Call Summaries Archive

Profile Development

Streamlined Profile (also on Profile page)

  • 32 pages including Conformance Checklists


Status - Balloting Streamlined Profile

The Technically Confirmed Profile is on the Profiles page.

Stage 4 Planning

Past and Future

Groundwork Projects

These projects investigate (and resolve) scientific questions underlying QIBA Profile work.

  • VolCT - Group 1A - Analyze Bias/Variance where Ground Truth is Known Deterministically
  • VolCT - Group 1B - Focus on Volume Change Analysis of Pulmonary Nodules in Diagnostic Settings
  • VolCT - Group 1C - Model Sources of Variability from a Systems Engineering Analysis
  • VolCT - Group 3A - Characterize variability due to algorithms (using phantoms / clinical data)
  • VolCT - Group 3B - Characterize clinical utility/efficacy with respect to clinical endpoints
  • VolCT - Colorado Group - Quantifying variability in measurement of pulmonary nodule

Reference Materials

2012

2011

2010

Reference Articles

  • Are we ready? A time for measurement of physiological parameters of the lung using multidetector row CT scans. Hatabu H. Acad Radiol. 2009 Mar; 16(3):249. Academic Radiology
  • Radiology 2007 - Coronary Calcium Scoring - This paper by Dr. McCollough et al is may be seen to be analaogous to our work in that it addresses similar issues (e.g. achieving "standard" noise levels). It could be thought of as an early draft of a Calcium Scoring profile, including both groundwork and equipment specifications.
  • Helical multidetector row quantitative computed tomography (QCT) precision. Bligh M, Bidaut L, White RA, Murphy WA Jr, Stevens DM, Cody DD. Acad Radiol. 2009 Feb; 16(2):150-9. Academic Radiology
  • Comparison of the accuracy of CT volume calculated by circumscription to prolate ellipsoid volume (bidimensional measurement multiplied by coronal long axis). Rkein AM, Harrigal C, Friedman AC, Persky D, Krupinski E. Acad Radiol. 2009 Feb; 16(2):181-6. Academic Radiology

QIBA Funded Projects

Round 1

Round 2

Round 3

Round 4

Round 5

Round 6

Retrieved from "https://qibawiki.rsna.org/index.php?title=CT_Volumetry_Biomarker_Ctte&oldid=18935"